F. Piacentini
0000-0002-5444-9327
Publication & Citation Trends
Publications
0 total
Abstract PS14-09: Central Nervous System as the Primary Site of First Relapse in Patients with Triple-Negative Breast Cancer Achieving Pathological Complete Response After Neoadjuvant Treatment
Cited by 0
Semantic Scholar
Locally advanced breast cancers: the EUSOMA experience.
Cited by 0
Semantic Scholar
Abstract P3-05-02: The impact of ethnicity on benefit from novel drugs approved for breast cancer treatment: a systematic review and meta-analysis of randomized phase 3 trials of the last decade
Cited by 0
Semantic Scholar
Prognostic role of estrogen receptor (ER) expression in breast cancer (BC) metastases and its dynamics from primary to metastatic disease: Results from a large multicentric cohort of patients with phenotypically stable ER+(≥10%)/HER2- BC.
Cited by 0
Semantic Scholar
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer OA
Cited by 11
Semantic Scholar
Abstract RF3-02: Efficacy of adjuvant avelumab by PD-L1, tumor infiltrating lymphocytes and residual cancer burden in high-risk triple negative breast cancer: secondary and exploratory endpoints of the phase III A-BRAVE trial
Cited by 0
Semantic Scholar
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications
Cited by 1
Semantic Scholar
A-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapy.
Cited by 25
Semantic Scholar
Research Topics
Cosmology and Gravitation Theories
(227)
Radio Astronomy Observations and Technology
(164)
Galaxies: Formation, Evolution, Phenomena
(160)
Superconducting and THz Device Technology
(102)
Dark Matter and Cosmic Phenomena
(81)
Affiliations
Université Paris-Sud
University of Rome Tor Vergata
California Institute of Technology
Centre National de la Recherche Scientifique
National Institute of Standards and Technology